Case Summary:

When an EB1-A (Alien of Extraordinary) client from China came to us for his application, our team made certain that he got the best service possible. So once the formality of signing the retainer had been done, we began preparing his petition on the basis of his academic and professional qualifications. Some of the factors that played a role in this are:

• He is one of the few leading next-generation sequencing, metabolite profiling, and cancer biology experts in biochemistry, and he has achieved a consistent and notable record of success and influence in these areas of study.
• His work has been widely published and extensively cited throughout the field, as well as awarded funding from major institutions.
• He has also been invited to conduct peer reviews and has completed at least 58 reviews for journals that include national and internationally recognized magazines of repute.
• He has also made original contributions of major significance to the field of biochemistry, including but not limited to investigating the toxicity of nanoparticles and quantum dots on mitochondria to improve medical imaging and drug delivery and examining the pro-apoptotic effects of honokiol on different cancer types.
• Not only this, but his biochemistry research also addresses some of our nation’s and the world’s most pressing issues, including the health and economic burden of cancer.
• Moreover, the 13 peer-reviewed scientific articles that he has published have also been cited 466 times by researchers in at least 35 countries according to Google Scholar, thereby demonstrating that these publications are widely recognized and relied upon in the field of biochemistry.
• Thus, not only has he shown that he meets at least three of the regulatory criteria, but the evidence in the aggregate also demonstrates his national and international acclaim and position at the very top of his field.
• Along with these factors, the 4 letters of recommendation that he had collected for his petition played a major role in corroborating the above evidence about his expertise. One of them said the following in their letter:

“More research into the underlying mechanisms of drug resistance is required to provide better cancer treatments and outcomes, as is research being conducted by [the client] into treatments and therapies that overcome known resistances. Specifically, [the client’s] research into the effects of inorganic materials and organic molecules on mitochondrial activity in cancer cells is key to finding better strategies and improved efficacy in fighting drug resistance in cancer.”

This ensured the success of his case because drug resistance and the rising rates of cancer are major points of concern for the U.S. healthcare system. So, when his approval came through just 1 month and 4 days later, we knew that it was due to our client’s excellent credentials and our case preparation strategy. We are glad that we could be of assistance to him on this journey and we thank him for choosing our firm to guide him in this matter.